Company / Operating Margin
Corcept Therapeutics Incorporated Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
5.9%
FY2025
5-year range
5.9% / 34.0%
FY2021-FY2025
Trend
-71.0%
vs FY2024
Sector context
#48 of 136
Health Care
What the data says
At 5.9%, Corcept Therapeutics Incorporated's operating margin ranks #48 of 136 in the Health Care sector. Operating Margin has declined for 5 consecutive years, from 36.2% in FY2020 to 5.9% in FY2025.
Based on SEC 10-K filings.
5.9% in FY2025 with a 5-year CAGR of -30.3%.
Declined from 22.2% to 5.9% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -22.1pp
- 5-Year Change
- -30.3pp
- 10-Year Change
- -
Sector benchmark
#48 of 136 in Health CareTop 35% of 136This company 5.9% Sector average -778.9%
▼
+100.8% above sector average
Key checks
Key Insights
- Corcept Therapeutics Incorporated's operating margin has declined for 5 consecutive years.
- In FY2025, operating margin decreased 71.0% year-over-year.
- Currently 784.8pp above the Health Care sector average.
- Peak operating margin was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 5.9% | -71.0% |
| FY2024 | 20.3% | -8.8% |
| FY2023 | 22.2% | -20.7% |
| FY2022 | 28.0% | -17.6% |
| FY2021 | 34.0% | -6.1% |
| FY2020 | 36.2% | +9.1% |
| FY2019 | 33.2% | +165.2% |
| FY2018 | 12.5% | -62.3% |
| FY2017 | 33.2% | +131.9% |
| FY2016 | -104.0% | -1418.5% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026